Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1995-7-12
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1061-4036
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
231-2
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7773283-Adenocarcinoma,
pubmed-meshheading:7773283-Colorectal Neoplasms,
pubmed-meshheading:7773283-HLA Antigens,
pubmed-meshheading:7773283-Humans,
pubmed-meshheading:7773283-Mutation,
pubmed-meshheading:7773283-Phenotype,
pubmed-meshheading:7773283-Tumor Cells, Cultured,
pubmed-meshheading:7773283-beta 2-Microglobulin
|
pubmed:year |
1995
|
pubmed:articleTitle |
Immune surveillance in colorectal carcinoma.
|
pubmed:publicationType |
Letter
|